Abstract:Background: Multi-parameter imaging technology, which is based on substance separation, helps to predict the pathological grade of tumors. When using dual-layer spectral-detector computed tomography (DLCT) to quantify tumor properties, different methods of placing regions of interest (ROIs) directly impact the measurement of parameters, thus affecting the clinical diagnosis of lesions. Consequently, in this study, we aimed to compare the performance of 2 different ROI plotting methods on DLCT in differentiating the histologic grade of hepatocellular carcinoma (HCC). Methods: This retrospective study included 48 consecutive patients with pathologically confirmed HCC, who underwent DLCT from May 2022 to March 2023. The attenuation value of conventional computed tomography (CT), electron density relative to water (EDW), normalized effective atomic number (NZeff), and normalized iodine density (NID) were measured by 2 radiologists using the conventional planar sketching (PS) method and the volumetric analysis method, respectively. The differences in parameters between the arterial phase (AP) and venous phase (VP) were calculated for each parameter (∆CT, ∆EDW, ∆NZeff, ∆NID). We used 2-sample t-test or Mann-Whitney U test was used to compare the differences in parameters between the 2 methods. Spearman correlation analysis was used to determine the correlation between each parameter and histologic grade. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance. Results: The mean values for the spectral quantitative parameters (CTAP, NZeffAP, NIDAP) and the difference between the arterial phase and venous phase (AP-VP) of parameters (∆CT, ∆EDW, ∆NZeff) measured using the volumetric analysis method were significantly lower than those of the PS method (P<0.05). For the ∆NZeff, the volumetric analysis method achieved the highest area under the curve (AUC) with a value of 0.918 [95% confidence interval (CI): 0.847-0.988], followed by the PS method (AUC =0.853, 95% CI: 0.743-0.963). Conclusions: The spectral parameters of DLCT provide a novel quantitative method for evaluating histological differentiation in patients with HCC, which is worthy of clinical recommendation. Different ROI plotting methods significantly impact the measurement of spectral parameters. Therefore, the whole tumor region should be covered in the parameter measurement of HCC lesions as much as feasible, which is more helpful in predicting the histological grading of tumors before treatment.

Hepatocellular carcinoma and focal nodular hyperplasia of the liver: differentiation with CT spectral imaging

Spectral CT Imaging in Differentiation between Focal Nodular Hyperplasia and Hepatocellular Carcinoma

Differentiation of Hepatocellular Carcinoma from Hepatic Hemangioma and Focal Nodular Hyperplasia Using Computed Tomographic Spectral Imaging

Values of Spectral CT Imaging in Differential Diagnosis of Hepatocellular Carcinoma and Focal Nodular Hyperplasia

Differentiation of Small Hepatic Hemangioma from Small Hepatocellular Carcinoma: Recently Introduced Spectral Ct Method

Differential Diagnosis of Hepatic Cancerous Nodules and Cirrhosis Nodules by Spectral CT Imaging: a Feasibility Study

Clinical value of energy spectrum CT in the differential diagnosis of liver cancer and FNH

The CT Spectral Diagnostic Value in the Diagnosis of Hepatocellular Carcinoma and Angiomyolipoma

Spectral Ct: Preliminary Studies In The Liver Cirrhosis

Parametric Imaging with Contrast-Enhanced Ultrasound: Usefulness for Characterization of Dynamic Effects of Microvascularization for Hepatocellular Carcinoma and Focal Nodular Hyperplasia.

Parametric Imaging with Contrast-Enhanced Ultrasound for Differentiating Hepatocellular Carcinoma from Metastatic Liver Cancer.

[Differentiation Between Hyperintense Hepatocellular Carcinoma and Focal Nodular Hyperplasia in Hepatobiliary Phase with Multimodal Parameters of Magnetic Resonance Imaging].

Spectral CT Imaging in Differentiating Pancreatic Carcinoma and Mass-forming Focal Pancreatitis

Quantitative Analysis of Contrast-Enhanced Ultrasonography: Differentiating Focal Nodular Hyperplasia from Hepatocellular Carcinoma

Prediction of histologic grade of hepatocellular carcinoma using dual-layer spectral-detector computed tomography (CT): comparison of two region of interest plotting methods

Differential Diagnosis Value of Quantitative Color Mapping of the Arterial Enhancement Fraction between Hepatic Focal Nodular Hyperplasia and Hepatocellular Carcinoma

Plane and Weighted Tri-Phase Helical CT Findings in the Diagnosis of Liver Focal Nodular Hyperplasia.

Preliminary Study of Spectral CT Dynamic Contrast-enhanced Imaging on the Diagnosis of Liver Cirrhosis

Spectral CT in Evaluating the Therapeutic Effect of Transarterial Chemoembolization for Hepatocellular Carcinoma

Diagnosis of the hepatic focal nodular hyperplasia by ultrasonography and CT

Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images